Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrighton Pier Regulatory News (PIER)

  • There is currently no data for PIER

Total Voting Rights

1 Feb 2018 07:00

RNS Number : 3492D
Brighton Pier Group PLC (The)
01 February 2018
 

1 February 2018

The Brighton Pier Group PLC

("Brighton Pier Group" or the "Company")

 

Total Voting Rights

 

For the purposes of the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules, the directors of the Company advise that as of the date of this notice the total number of ordinary shares of 25p each in issue is 35,664,010 with each share carrying the right to one vote.

There are no ordinary shares held in treasury.

The total number of voting rights in the Company is therefore 35,664,010.

The above figures may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules. 

Enquiries:

 

The Brighton Pier Group Plc

 

Tel: 020 7376 6300

Luke Johnson, Executive Chairman

Anne Ackord, Chief Executive Officer

John Smith, Chief Financial Officer

Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker )

Tel: 020 7886 2500

Corporate Finance

Andrew Godber / Atholl Tweedie / Edward Phillips

Corporate Broking

Charles Leigh-Pemberton

Arden Partners plc (Joint Broker)

Tel: 0207 7614 5900

Corporate Finance

John Llewellyn-Lloyd / Benjamin Cryer

Corporate Broking

Jonathan Keeling

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRWGUGUGUPRGPU
Date   Source Headline
8th Oct 20217:00 amRNSTrading Statement
7th Oct 20212:06 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
17th Jun 202112:00 pmRNSAcquisition of Lightwater Valley Attractions
12th Apr 20212:09 pmRNSBlock listing Interim Review
9th Apr 20215:14 pmRNSHolding(s) in Company
29th Mar 20217:00 amRNSHalf-year Report
26th Feb 20211:10 pmRNSChange of Adviser
23rd Feb 20212:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20212:01 pmRNSPrice Monitoring Extension
12th Feb 20212:37 pmRNSCovid-19 update
2nd Dec 202012:43 pmRNSResult of Annual General Meeting
2nd Nov 20207:00 amRNSFinal Results
12th Oct 20207:00 amRNSBlock Listing Return
14th Sep 20207:00 amRNSTrading Update
14th May 20207:00 amRNSCovid-19 Update
4th May 20207:35 amRNSBlock listing Interim Review
14th Apr 20209:05 amRNSSecond Price Monitoring Extn
14th Apr 20209:00 amRNSPrice Monitoring Extension
19th Mar 20204:11 pmRNSTR-1 Notification
17th Mar 20207:00 amRNSInterim Results
30th Jan 20206:13 pmRNSHolding(s) in Company
6th Dec 20198:45 amRNSResult of Annual General Meeting
14th Nov 20192:45 pmRNSAnnual Report 2019
11th Oct 20192:31 pmRNSBlock Listing Six Monthly Return
23rd Sep 20197:00 amRNSFinal Results
28th Aug 20198:38 amRNSTR-1 Notification
10th Apr 20197:00 amRNSBlock listing Interim Review
26th Mar 20197:05 amRNSDirectorate Change
26th Mar 20197:00 amRNSInterim Results
11th Mar 20196:13 pmRNSHolding(s) in Company
7th Mar 20196:14 pmRNSHolding(s) in Company
15th Feb 20193:23 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSDirectorate Change
10th Jan 20197:00 amRNSTrading Update
19th Dec 20187:58 amRNSHolding(s) in Company
7th Dec 201812:18 pmRNSResult of AGM
4th Dec 20188:22 amRNSHolding(s) in Company
3rd Dec 20184:58 pmRNSHolding(s) in Company
3rd Dec 20184:56 pmRNSHolding(s) in Company
3rd Dec 20182:46 pmRNSAnnual Financial Report
3rd Dec 20189:35 amRNSHolding(s) in Company
23rd Nov 20184:07 pmRNSAdditional Listing
16th Nov 20183:26 pmRNSHolding(s) in Company
9th Oct 20181:36 pmRNSBlock listing Interim Review
25th Sep 20187:00 amRNSFinal Results
16th May 20183:43 pmRNSHolding(s) in Company
10th Apr 20187:00 amRNSBlock listing Interim Review
27th Mar 20187:00 amRNSInterim Results
1st Feb 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.